| ACN | Acetonitrile |
| ALOGPS | Aqueous logP Prediction System |
| AUCxh | Area under the plasma concentration–time curve from time zero to x hours after dosing |
| AUC∞ | Area under the plasma concentration–time curve from time zero to infinity |
| BSA | Bovine serum albumin |
| C0h | Plasma concentration at time zero after dosing |
| Cmax | Maximal plasma concentration |
| DMSO | Dimethylsulfoxide |
| Fabs | Fraction absorbed |
| Fdiss | Fraction dissolved |
| HPLC | High-performance liquid chromatography |
| ISG | In situ gel |
| IV | Intravenous |
| IVIVC | In vitro–in vivo correlation |
| IVR | In vitro release |
| K2.EDTA | Potassium ethylenediaminetetraacetic acid |
| K | In vitro Korsmeyer–Peppas release rate constant |
| LAI | Long-acting injectable |
| LC-MS/MS | Liquid chromatography–tandem mass spectrometry |
| L:G | Lactide/glycolide ratio |
| Max | Maximum |
| Min | Minimum |
| mPEG-PLA | Methoxy-poly(ethylene glycol)-co-poly(D,L-lactide) |
| MW | Molecular weight |
| N | Sample size |
| NMP | N-methyl-2-pyrrolidone |
| n | In vitro Korsmeyer–Peppas release exponent |
| PDA | Photodiode array |
| PK | Pharmacokinetic(s) |
| PLA | Poly(D,L-lactide) |
| PLGA | Poly(D,L-lactide-co-glycolide) |
| PLA-PEG-PLA | poly(D,L-lactide)-co-poly(ethylene glycol)-co-poly(D,L-lactide) |
| PVDF | Polyvinylidene fluoride |
| SD | Standard deviation |
| SLS | Sodium lauryl sulphate |
| t1/2 | Half-life |
| TFA | Trifluoroacetic acid |
| UHPLC | Ultra-high-performance liquid chromatography |